|Bid||30.81 x 1000|
|Ask||36.00 x 800|
|Day's Range||30.42 - 31.37|
|52 Week Range||21.83 - 39.78|
|Beta (5Y Monthly)||1.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 02, 2023 - May 08, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||48.00|
Subscribe to Yahoo Finance Plus to view Fair Value for EVH
Evolent Health, Inc. ( NYSE:EVH ) shareholders might be concerned after seeing the share price drop 12% in the last...
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations, Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations.
Evolent Health ( NYSE:EVH ) Full Year 2022 Results Key Financial Results Revenue: US$1.35b (up 49% from FY 2021). Net...